11
|
|
|
MacroH2A.1 histone |
H2A.y, H2A/y, H2AF12M, H2AFY, MACROH2A1.1, mH2A1, macroH2A1.2 |
|
12
|
|
|
Mitotic arrest deficient 1 like 1 |
MAD1, MVA7, PIG9, TP53I9, TXBP181 |
Alzheimer disease, Anorexia nervosa, Anxiety disorder, Juvenile arthritis, Asthma, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Breast cancer, Cardiovascular disease, Clear cell renal cell carcinoma, Conduct disorder, Coronary artery disease, Crohn disease, Major depressive disorder, Hypertension, Prostate cancer, Gastroesophageal reflux disease, Generalized anxiety disorder, Gout, Heart failure, Hyperpituitarism, Idiopathic pulmonary fibrosis, Inflammatory bowel disease, Insomnia, Juvenile idiopathic arthritis, Kidney cancer, Metabolic syndrome, Migraine, Mood disorder, Mosaic variegated aneuploidy, Myeloproliferative disorder, Myocardial infarction, Neurotic disorder, Obesity, Obsessive-compulsive disorder, Open angle glaucoma, Parkinson disease, Oligoarticular juvenile idiopathic arthritis, Peptic ulcer disease, Post-traumatic stress disorder, Prostatic neoplasms, Schizoaffective disorder, Schizophrenia, Substance abuse, Testicular carcinoma, Testicular germ cell tumor, Tourette syndrome, Diabetes mellitus type 2, Ulcerative colitis, Urinary bladder cancerView all (36 more) |
13
|
|
|
Mitotic arrest deficient 2 like 1 |
HSMAD2, MAD2 |
|
14
|
|
|
Mitotic arrest deficient 2 like 2 |
FANCV, MAD2B, POLZ2, REV7 |
|
15
|
|
|
Mucosal vascular addressin cell adhesion molecule 1 |
MACAM1 |
|
16
|
|
|
MAP kinase activating death domain |
DEEAH, DENN, IG20, NEDDISH, RAB3GEP, RabGEF |
Alzheimer disease, Autism, Breast cancer, Kidney disease, Corneal astigmatism, Deeah syndrome, Hypertension, Metabolic syndrome, Migraine, Neurodevelopmental disorder, Neurotic disorder, Non-specific syndromic intellectual disability, Open angle glaucoma, Diabetes mellitus type 2 |
17
|
|
|
Macrophage erythroblast attacher, E3 ubiquitin ligase |
EMLP, EMP, GID9, HLC-10, P44EMLP, PIG5 |
|
18
|
|
|
Maelstrom spermatogenic transposon silencer |
CT128, SPATA35 |
|
19
|
|
|
MAF bZIP transcription factor |
AYGRP, CCA4, CTRCT21, c-MAF |
Alzheimer disease, Androgenetic alopecia, Bipolar disorder, Bone fracture, Cataract-microcornea syndrome, Cataract, Congenital cataract, Cataract-multisystem syndrome, Cholelithiasis, Colorectal neoplasms, Cystic kidney disease, Dental caries, Rolandic epilepsy, Developmental and epileptic encephalopathy, Global developmental delay, Hypothyroidism, Intrahepatic cholestasis, Kidney disease, Multiple sclerosis, Obesity, Peripheral arterial disease, Schizophrenia, Spinocerebellar ataxia, Diabetes mellitus type 1, Diabetes mellitus type 2, Urinary system diseaseView all (11 more) |
20
|
|
|
MAF1 negative regulator of RNA polymerase III |
- |
|
